Research & Development
Policy & Regulation
Trends & Finance
CDC’s five-day isolation period after COVID infection may not be sufficient
Stanford University researchers have published findings indicating that rapid antigen tests remained positive in 27% of the participants in a study after seven days of isolation.
October 19, 2022
Week in Review: Multicancer early detection at ESMO, DiaSorin nabs FDA clearance for COVID-19 kit, IVD industry urges Congress to enact SALSA, and more
Dear LabPulse.com member,
September 14, 2022
AACC calls for policies on AI in medical, healthcare fields
The AACC is also calling for the federal government to increase funding for the U.S. Centers for Disease Control and Prevention's ongoing effort to harmonize laboratory test results. It also said federal policy should prioritize payment reforms that promote secure, ethical, and reciprocal data sharing among health systems and providers.
July 29, 2021
Revival of VALID Act draws mixed response
The issue of diagnostics regulation has emerged as a political lightning rod, with some faulting the Trump administration's response to the outbreak and others blaming what they claim is a history of federal overregulation of clinical labs.
March 8, 2020
CAP paints rosy picture of pathology jobs
CAP leaders tackled workforce issues and pessimistic sentiment among residents about the outlook for employment in pathology during a panel at the meeting, which runs from September 21-25 at the Gaylord Palms Resort and Convention Center in Kissimmee, FL, near Orlando.
September 24, 2019
CAP: Action on surprise medical bills may collapse, despite bipartisan support
Surprise billing is at the forefront of issues on CAP's advocacy agenda, said Dr. Donald Karcher, chair of CAP's Council on Government and Professional Affairs. He moderated a panel on timely advocacy topics at the meeting, which is being held at the Gaylord Palms Resort and Convention Center in Kissimmee, FL, near Orlando.
September 22, 2019
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
Point-of-care testing tackles diabetes risk in Texas
Public health officials in Denton County decided to take advantage of POC testing's unique capabilities to address a rising diabetes incidence rate among low-income people in their area. As a result of its efforts, the department boosted hemoglobin A1c (HbA1c) testing rates and achieved a 38% overall reduction in HbA1c levels in this target population.
September 11, 2019
Page 1 of 1